Angioneurotic orolingual edema associated with the use of rt-PA following a stroke;Angioneurotisches orolinguales ödem nach rt-PA-lyse eines schlaganfalls

Anaesthesist

Volumn 56, Issue 10, 2007, Pages 1024-1027

  Laubinger, R ^a   Guthke, K ^a   Erdmann, U ^a   Klein, U ^a  

^a Südharz Hospital   (Germany)

Author keywords

ACE inhibitor; Angioneurotic edema; C1 esterase inhibitor; Thrombolysis with rt PA Stroke

Indexed keywords

ALTEPLASE; CLEMASTINE; CLOPIDOGREL; COMPLEMENT COMPONENT C1S INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; RANITIDINE; SIMVASTATIN; COMPLEMENT COMPONENT C1S; FIBRINOLYTIC AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; FIBRINOLYTIC THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; STROKE; TONGUE EDEMA; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; EDEMA; FEMALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PATHOLOGY; TONGUE DISEASE;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLEMASTINE; COMPLEMENT C1S; EDEMA; FEMALE; FIBRINOLYTIC AGENTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MIDDLE AGED; NEUROLOGIC EXAMINATION; RANITIDINE; RECOMBINANT PROTEINS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TONGUE DISEASES;

EID: 35848935244     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1237-2     Document Type: Article

References (15)

1. Bennet WR, Yawn DH, Tanswell P et al. (1987) Activation of the complement system by recombinant tissue plasminogen activator. J Am Coll Cardiol 10: 627-632
2. Brott T, Adams HP, Olinger CP et al. (1989) Measurements of acute cerebral infarction: A clinical examination scale. Stroke 20: 864-870
3. Byrd JB, Adam A, Brown NJ (2006) Angiotensin converting enzyme inhibitor associated angioedema. Immunol Allergy Clin North Am 26: 725-737
4. Campell DJ, Krumm H, Esler MD (2005) Losartan increases bradykinin levels in hypertensive humans. Circulation 111: 315-320
5. Cugno M, Cicardi M, Colucci M et al. (1996) Non neutralizing antibodies to tissue type plaminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. Thromb Haemost 76: 234-238
6. Donaldson VH (1993) Plasminogen activation in hereditary angioneurotic edema. J Lab Clin Med 12: 13-14
7. Entgelter ST, Fluri F, Buitrago-Tellez C et al. (2005) Life threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 252: 1167-1170
8. Hill MD, Buchan AM, Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators (2005) Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 172: 1307-1312
9. Hill MD, Philip A, Barber A et al. (2000) Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 162: 1281-1284
10. Hellebrand MC, Kojda G, Hoffmann TK, Bas M ( 2006) Angioödeme durch ACE-Hemmer und AT1-Rezeptorblocker. Hautarzt 57: 808-810
11. Jobst R, Grond M, Prince WS et al. (1999) Evidence of anaphylaxis after alteplase infusion. Stroke 30: 1142-1143
12. Malde B, Regalado J, Greenberger PA (2007) Investigation of angioedema associatetd with the use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 98: 57-63
13. Sica DA,Black HR (2002) Angioedema in heart failure: Occurence with ACE inhibitor and safety of angiotensin rezeptor blocker therapy. Congest Heart Fail 8: 334-341
14. Topol EJ, Morris DC, Smalling RW et al. (1987) A multi centre randomized placebo controlled trial of a new form of intravenous recombinat tissue type plasminogen activator in acute myocardial infarction. J Am Coll Cardiol 9: 1205-1213
15. Yoon BW, Morillo CA, Cechetto DR, Hachinski V (1997) Cerebral hemispheric lateralization in cardiac autonomic control. Arch Neurol 54: 741-744